Group One Trading, L.P. Zai Lab LTD Transaction History
Group One Trading, L.P.
- $2.54 Billion
- Q4 2024
A detailed history of Group One Trading, L.P. transactions in Zai Lab LTD stock. As of the latest transaction made, Group One Trading, L.P. holds 5,030 shares of ZLAB stock, worth $187,568. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,030
Previous 4,084
23.16%
Holding current value
$187,568
Previous $98,000
33.67%
% of portfolio
0.01%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ZLAB
# of Institutions
145Shares Held
46.3MCall Options Held
103KPut Options Held
439K-
Janus Henderson Group PLC London, X06.57MShares$245 Million0.09% of portfolio
-
Capital World Investors Los Angeles, CA6.43MShares$240 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.17MShares$118 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$93.6 Million1.07% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.35MShares$87.8 Million0.01% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.65B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...